Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Leukemia|December 22, 2018
PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemiaBola S Hanna, Philipp M Roessner, Annika Scheffold, et al.
Cancer Research|February 22, 2012
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cellsValentina Kovaleva, Rodrigo Mora, Yoon Jung Park, et al.
Cancers|June 16, 2019
Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic LeukemiaLena Schulze-Edinghausen, Claudia Dürr, Selcen Öztürk, et al.
Haematologica|March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapyMarc Zapatka, Eugen Tausch, Selcen Öztürk, et al.
Blood|June 24, 2015
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblastsJerome Paggetti, Franziska Haderk, Martina Seiffert, et al.
Leukemia|June 15, 2019
Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemiaNeus Giménez, Ralph Schulz, Morihiro Higashi, et al.
British Journal of Haematology|November 15, 2019
TBET-expressing Th1 CD4<sup>+</sup> T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 micePhilipp M Roessner, Bola S Hanna, Selcen Öztürk, et al.
Leukemia|September 30, 2018
Control of chronic lymphocytic leukemia development by clonally-expanded CD8<sup>+</sup> T-cells that undergo functional exhaustion in secondary lymphoid tissuesBola S Hanna, Philipp M Roessner, Haniyeh Yazdanparast, et al.
Blood Advances|September 29, 2021
An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodiesTobias Roider, Berit J Brinkmann, Vladislav Kim, et al.
Cell Death & Disease|February 10, 2023
A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectorsAlessia Floerchinger, Jessica E Klein, Maximiliane S C Finkbeiner, et al.
Pageof 7